Prothena Corp. plc Stock
Prothena Corp. plc Stock
Prothena Corp. plc gained 2.080% today.
Prothena Corp. plc is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
Based on the current price of 19.5 € the target price of 81 € shows a potential of 315.38% for Prothena Corp. plc which would more than double the current price.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 2.080% | 1.036% | -15.217% | -59.711% | -43.966% | -12.162% | - |
| Ardelyx Inc. | 3.670% | -0.366% | -11.361% | 47.951% | 3.668% | -1.770% | - |
| Salarius Pharmaceuticals Inc. | -2.830% | -3.738% | -2.830% | -71.389% | -25.766% | -98.474% | -99.994% |
| Brainstorm Cell | 7.270% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $98.00 to $80.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat